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ABSTRACT: Dietary inorganic nitrate prevents aspects of cardiac mitochondrial dysfunction induced by hypoxia,
although themechanism is not completelyunderstood. Inbothheart and skeletalmuscle, nitrate increases fatty acid
oxidation capacity, and in the latter case, this involves up-regulation of peroxisome proliferator-activated receptor
(PPAR)a expression. Here,we investigatedwhether dietary nitratemodifiesmitochondrial function in the hypoxic
heart in a PPARa-dependentmanner.Wild-type (WT)mice andmicewithout PPARa (Ppara2/2) were givenwater
containing 0.7 mMNaCl (control) or 0.7 mMNaNO3 for 35 d. After 7 d, mice were exposed to normoxia or hypoxia
(10% O2) for the remainder of the study. Mitochondrial respiratory function and metabolism were assessed in
saponin-permeabilized cardiac muscle fibers. Environmental hypoxia suppressed mass-specific mitochondrial
respiration and additionally lowered the proportion of respiration supported by fatty acid oxidation by 18% (P <
0.001).This switchaway from fatty acid oxidationwas reversedbynitrate treatment inhypoxicWTbutnotPpara2/2
mice, indicating a PPARa-dependent effect. Hypoxia increased hexokinase activity by 33% in all mice, whereas
lactate dehydrogenase activity increased by 71% in hypoxicWT but not Ppara2/2mice. Our findings indicate that
PPARa plays a key role inmediating cardiacmetabolic remodeling in response to both hypoxia and dietary nitrate
supplementation.—Horscroft, J. A.,O’Brien, K.A., Clark, A.D., Lindsay, R. T., Steel, A. S., Procter, N. E. K., Devaux,
J., Frenneaux, M., Harridge, S. D. R., Murray, A. J. Inorganic nitrate, hypoxia, and the regulation of cardiac mito-
chondrial respiration—probing the role of PPARa. FASEB J. 33, 000–000 (2019). www.fasebj.org
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The mammalian heart is often described as a metabolic
omnivore, in reference to its ability to oxidize a variety of
substrates in order tomeetATPdemands (1).Although the
healthy heart predominantly uses fatty acid oxidation
(FAO) to meet these requirements under fasting condi-
tions, underhypoxic conditions, FAO isdown-regulated in
favorof a relative increase inglucosemetabolism (2),which
requires less O2 per ATP synthesized (1). Key to this re-
sponse is a reduction in the expression of peroxisome
proliferator-activated receptor (PPAR)a, a ligand-activated
transcription factor expressed in liver, heart, kidney, and to
a lesser extent skeletal muscle (3). When activated, PPARa
increases the expression of a number of genes involved in
mitochondrial fatty acid import [e.g., carnitine palmitoyl-
transferase 1b (Cpt1b)] andb-oxidation [e.g., 3-hydroxyacyl
dehydrogenase (Hadh), Acyl-CoA Dehydrogenase Me-
dium Chain (Acadm), Uncoupling protein 3 (Ucp3)] (3). In
mice, cardiac-specific ablation of the hypoxia-inducible
factor (HIF)-1b, increased PPARa expression and tran-
scriptional activity, and also increased FAO (4), suggesting
thatHIFsignalingattenuatesPPARa inhypoxia. Indeed, in
cardiomyocytes, HIF-1a activation decreased PPARa
DNA binding activity (5). In addition to a suppression of
FAO,mitochondrial pyruvate oxidation is also suppressed
in hypoxia via the phosphorylation of pyruvate de-
hydrogenase (PDH) by pyruvate dehydrogenase kinase 1
(PDK1), which is induced byHIF-1a in hypoxic cells (6, 7).
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Thus, mitochondrial respiration would be suppressed in
favor of glycolytic ATP production.
In the hypoxic rodent heart, the transcriptional activity
of PPARa is down-regulated in association with a sup-
pression of FAO (8, 9) and an increase in glycolysis (8). As
such, the cardiac metabolic phenotype of hypoxic mice
resembles that of mice without PPAR receptor (Ppara2/2),
and notably, no further suppression of FAO occurs in
Ppara2/2 mice following exposure to hypoxia (8). More-
over, although hypoxic exposure results in an impaired
cardiac energetic reserve in both humans (10) and rodents
(8), increasing PPARa activity and FAO in hypoxic mice
through a high-fat diet did not improve energetics and in
fact worsened contractile function (8), thus it appears that
down-regulation of FAO in the hypoxic heart is protective.
Recent work, however, has suggested that both FAO and
energeticsmight bepreserved in hypoxic tissues bydietary
supplementation with inorganic nitrate (NO3
2).
Dietary inorganicNO3
2 is principally acquired through
the consumption of leafy, green vegetables and has effects
on mitochondrial function, which may be beneficial to
human health (11). NO3
2 is reduced to nitrite (NO2
2) via
oral NO3
2 reductase in commensal bacteria (12). NO2
2 is
then converted to NO in the stomach by acid dispropor-
tionation (13) and is absorbed into the bloodstream in
which it can be oxidized to NO2
2 by ceruloplasmin (14) or
to NO3
2 by hemoglobin (15). Under conditions of moder-
ate hypoxia or acidosis or both, NO2
2may be reduced to
NOby one of severalNO2
2 reductases, including xanthine
oxidoreductase (16), deoxyhemoglobin (17), deoxy-
myoglobin (18), and eNOS (19). Under such conditions,
endogenousNOproduction fromL-arginine andO2 via the
NOS enzymes is attenuated because of the low partial
pressureofO2; thus,NO3
2supplementationmaypreventa
hypoxia-induced fall in NO bioavailability.
A major physiologic role of NO is to induce vasodila-
tationupon its release from the endothelium in response to
a range of stimuli (20). NO binds to the heme group of
soluble guanylyl cyclase inducing cGMP production (21).
This in turn activates cGMP-dependent protein kinase G,
which results in smooth muscle relaxation and vaso-
dilatation via a reduction in intracellular [Ca2+] (22), thus
enhancing blood flow and O2 delivery. Additionally,
supplementation with moderate doses of dietary NO3
2
partially offsets the rise in circulating erythropoietin and
hemoglobin in hypoxic rats (23), whichmight prevent the
microcirculatorydysfunction associatedwith an increased
hematocrit (24), further improving O2 delivery. Indeed,
native Tibetan highlanders have high levels of plasma
NO3
2 (25) and lower blood-hemoglobin concentrations
([Hb]b) than acclimatised lowlanders at any given altitude
(26), and this is associated with superior forearm blood
flow (25). Supplementation of dietary NO3
2 under hyp-
oxic conditions may therefore preserve O2 delivery to re-
spiring tissues.
In addition to the effects on O2 delivery, NO regulates
multiple aspects of oxidative metabolism in respiring tis-
sues. NO induces mitochondrial biogenesis through the
up-regulation of PPARg coactivator 1a (27). Within mito-
chondria, NO competes with O2 at complex IV of the elec-
tron transfer system (ETS), leading to partial inhibition of
electron transport and control over reactive oxygen species
signaling (28).NOalso reactswith the superoxide ion (O2
2)
to form peroxynitrite (29), which acts as an endogenous
toxicant (30).Moreover,NOcan induce a post-translational
modification of complex I via S-nitrosation, resulting in its
inhibition (31), which has implications both for respiratory
function and reactive oxygen species production.
It has been reported that supplementation with dietary
NO3
2 lowers the O2 cost of exercise in humans (32) by
increasing mitochondrial thermodynamic efficiency (11),
and accordingly, NO3
2 could be beneficial in hypoxia. In
the hypoxic rat heart, NO3
2 supplementation prevented
the down-regulation of ETS complex I expression and
activity and the depression of mitochondrial FAO while
lowering markers of oxidative stress and protecting ATP
levels (33). It is not clear, however, whether this NO3
2-
mediated protection resulted from a direct effect on the
cardiomyocyte or through improvements in O2 delivery
that offset the challenge of hypoxia. Notably, however,
NO3
2 supplementation enhanced mitochondrial FAO
capacity in both the heart (33) and skeletal muscle (34) of
normoxic rats. Mechanistically, NO3
2 increased PPARa
transcriptional activity in skeletalmuscle,with no increase
in FAO seen in Ppara2/2 mice (34). Moreover, a similar
effect on PPARa transcription was seen in cultured myo-
cytes under constant, well-oxygenated conditions (34),
suggesting a role for NO3
2 supplementation beyond any
influence of NO on hemodynamics.
Dietary NO3
2, therefore, protects b-oxidation in the
hypoxic heart (33) and increases b-oxidation in skeletal
muscle via PPARa activation (34). PPARa transcriptional
activity is suppressed in the hypoxic rodent heart, al-
though expression of PPARa itself may be unchanged (9).
The interaction betweenNO3
2 and PPARa in the hypoxic
heart, however, remains unclear, and more specifically, it
is notknownwhetherPPARa is essential for theprotective
effects on mitochondrial respiratory function and FAO
elicited by NO3
2. We therefore investigated this in wild-
type (WT) mice (Ppara+/+) and Ppara2/2 mice that were
exposed to environmental hypoxia or normoxia with and
without supplementation with a moderate concentration
of dietary NO3
2. We previously reported that NO3
2 pro-
tected aspects of skeletalmusclemitochondrial respiratory
function in these mice in hypoxia and found this occurred
independently of PPARa (35). However, it has been sug-
gested that in the skeletal muscle of Ppara2/2 mice, high
expression of PPARb/d compensates for the loss of
PPARa (36). Moreover, expression of PPARa is higher in
heart than skeletalmuscle (3).Here,we focused on the role
of PPARa in NO3
2-mediated effects on the hypoxic heart,
hypothesizing that NO3
2 regulates mitochondrial func-
tion and b-oxidation in the hypoxic heart in a manner
dependent upon PPARa activity.
MATERIALS AND METHODS
Animal work was carried out in accordance with United King-
dom Home Office regulations under the Animals in Scientific
Procedures Act, and underwent review by the University of
Cambridge Animal Welfare and Ethical Review Committee.
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Procedures involving live animals were carried out by a license
holder in accordance with these regulations.
Study design
The overall study design has been previously described (35).
Mice were bred on a pure 129Ev/Sv background with 10 back-
crosses. The original breeding pairs of Ppara+/+ and Ppara2/2
mice were a kind gift of Frank Gonzalez [National Institutes of
Health (NIH), Bethesda, MD, USA]. Mice were housed in a
temperature-, humidity-, and light-controlled environment
(23°C) from birth with a 12-h light/dark cycle. Normoxic mice
were housed under the same environmental conditions as those
in the hypoxia chamber. Mice were provided with a standard
quality-controlleddietRM1(E) (65.0%carbohydrate, 13.1%crude
protein, 3.5% crude fat, 10 mg/kg NO3
2, trace NO2
2; Special
Diet Services, Essex, United Kingdom) and distilled water
ad libitum. At 6 wk of age, mice from each genotype were ran-
domly assigned to receive sodium chloride (0.7 mM) as a control
orsodiumNO3
2 (0.7mMNaNO3) in theirdrinkingwater.After a
further 7 d, mice from each genotype/treatment combination
were equally and randomly assigned to remain under normoxic
conditions (21% O2) or transferred to hypoxic (10% O2) condi-
tions in a hypoxia chamber (PFI Systems,Milton Keynes, United
Kingdom). Mice were maintained under these conditions for
28 d (Fig. 1). Body mass, food intake, and water intake were
measured weekly.
Mice were killed 80 6 4 d after birth by dislocation of the
neck. The chest cavity was opened, and the heart was re-
moved and immediately placed in an ice-cold biopsy preser-
vation medium, comprising 2.77 mM CaK2EGTA, 7.23 mM
K2EGTA, 6.56 mM MgCl2×6H2O, 20 mM taurine, 15 mM
phosphocreatine, 20 mM imidazole, 0.5 mM DTT, 50 mM 4-
morpholineethanesulfonic hydrate, and 5.77 mM Na2ATP,
pH 7.1. The heart was blotted and trimmed of extraneous
tissue before being separated into 3 sections: the apex was
kept in ice-cold biopsy preservation medium for high-
resolution respirometry, whereas the middle section and
base were snap frozen in liquid nitrogen. Meanwhile, a
droplet of blood was collected from the tail vein and loaded
into a microcuvette to quantify [Hb]b using a HemoCue Hb
201 Analyzer (Quest Diagnostics, Angelholm, Sweden).
High-resolution respirometry
Muscle fiber bundles were dissected from the heart and per-
meabilized using saponin as previously described (37). Mito-
chondrial respiratory function was assessed at 37°C using an
Oxygraph-2K (Oroboros Instruments, Innsbruck, Austria)
in respiratory medium comprising 0.5 mM EGTA, 3 mM
MgCl2.6H2O, 20 mM taurine, 10 mM KH2PO4, 20 mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 1 mg/ml
bovine serum albumin, 60 mM K-lactobionate, and 110 mM
sucrose, pH 7.1. Respiratory medium was hyperoxygenated at
the start of each experiment and periodically throughout each
assay by lifting the stopper of the oxygraph chamber slightly to
introduce a gas phase; thiswas done before injecting pureO2 gas
into the gas phase and then resealing the chamber once the de-
sired O2 concentration was reached. O2 concentrations in the
chambers were thus maintained between 250 and 500 mM in
order to negate limitations associated with O2 diffusion (37); all
reported respiratory fluxes were recorded within this range.
Two substrate-inhibitor titration assays were performed to
investigate respiratory control of different components of the
mitochondrial system. Assay 1 was based on a previously de-
scribed protocol (38) with the concentrations optimized for per-
meabilized cardiac fibers and was designed to investigate
b-oxidationof fattyacids.Assay2wasadapted fromapreviously
described protocol (39) and aimed to characterize control of dif-
ferent substrate-supported pathways over oxidative phosphor-
ylation (oxphos).
Assay 1
The addition of malate (2 mM), plus substrates for CPT1, pal-
mitoyl coenzyme A (40 mM), and carnitine (5 mM), resulted in
nonphosphorylating respiration (LEAK) constrained by the ac-
tivity of CPT1 (CPT1L). ADP (10 mM) resulted in oxphos also
constrained by CPT1 (CPT1P). In order to bypass CPT1 and in-
vestigate b-oxidation capacity (PalMP), palmitoyl carnitine
(20mM)was added. Finally, cytochrome c (10mM)was added to
assess the integrity of the outer mitochondrial membrane.
Assay 2
Administration of octanoyl carnitine (0.2 mM) with malate
(2 mM) resulted in LEAK respiration (OctML). ADP (10 mM)
addition resulted in oxphos respirationdependent onb-oxidation
of medium chain fatty acids (OctMP). Pyruvate (5 mM) was then
added (PMP), followed by glutamate (10mM) to support electron
flux through the N-pathway via complex I (GMP). Succinate
(10 mM) was then administered to additionally support electron
flux through the S-pathway via complex II (GMSP). Following
this, cytochrome c (10 mM) was added to assess mitochondrial
membrane integrity before rotenone (0.5 mM) was administered
Figure 1. Study design. Each stage of the study
took place within the ages shown 64 d, and the
length of each stage was identical for each
mouse. The left-hand section represents mice
with PPARa receptor (Ppara+/+), whereas the
right-hand section represents mice without
(Ppara2/2). The number in brackets indi-
cates the number of mice per group. Chloride,
0.7 mM NaCl in distilled water ad libitum; NO3
2,
0.7 mM NaNO3 in distilled water ad libitum;
normoxia, 21% atmospheric O2; hypoxia, 10%
atmospheric O2.
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to inhibit complex I and restrict electron flux to the S-pathway via
complex II (SP).
Coupling control ratios
In both assays, the oxphos coupling efficiency (j) (i.e., the pro-
portion of oxphos capacity that could not be explained byLEAK-
limited respiration), was calculated as Eq. 1.
j ¼ P2 L
P
(1)
where j is the oxphos coupling efficiency, L is the LEAK respi-
ration rate, and P is the oxphos respiration rate.
Substrate control ratios
The flux control of CPT1 over b-oxidation was assessed from
assay1byexpressingCPT1-limitedoxphosas a ratioofb-oxidation-
limited oxphos to give a flux control ratio (FCR) in Eq. 2:
FCRCPT1 ¼ CPT1PPalMP (2)
Fromassay 2, oxphos supported by the F-pathway (viab-oxidation;
Eq. 3), theN-pathway (via complex I; Eq. 4), and the S-pathway (via
complex II; Eq. 5) were expressed as a ratio of maximal oxphos to
discern the proportion of oxygen flux controlled by these pathways
as follows:
FCRF ¼ OctMPGMSP (3)
FCRN ¼ GMPGMSP (4)
FCRS ¼ SPGMSP (5)
Finally, the ratio of oxphos supported by octanoyl carnitine and
malate to oxphos supported by pyruvate and malate in assay 2
wasusedas an indicator of the relativecapacity for fattyacidsas a
substrate for mitochondrial respiration (Eq. 6):
FCRFA=P ¼ OctMPPMP (6)
Enzyme activity assays
Cardiac muscle homogenates were prepared from the con-
tents of the oxygraph chamber. In brief, the entire contents of
each chamber were removed, and the chambers were washed
with 2 ml respiratory medium. The original contents and
wash were combined with 2 ml of protease inhibitor (Com-
plete Protease Inhibitor Cocktail; Roche, Basel, Switzerland)
and 40 ml of Triton X-100 (1%). The solution was then ho-
mogenized using a Polytron (25,000 rpm, 30 s) (PT-10-35 GT;
Kinematic, Lucerne, Switzerland). The homogenate was
centrifuged (10,000 rpm, 10 min, 4°C) and the supernatant
removed and stored at 280°C until use.
In addition, whole tissue homogenates were prepared. Ap-
proximately 10 mg of cardiac muscle from the midsection of
the heart was homogenized with an Eppendorf pestle in an
Eppendorf tube containing 300 ml of homogenization buffer
(20 mM HEPES, 1 mM EDTA, 0.1% Triton X-100, pH 7.2). The
samples were then centrifuged (1000 g, 30 s, 4°C) and the su-
pernatant collected.
Protein concentration of chamber and tissue homogenates
wasmeasured using theQuick Start Bradfordprotein assay (Bio-
Rad, Hercules, CA, USA).
Enzyme activity assays were carried out at 37°C using an
Evolution 220 spectrophotometer (Thermo Fisher Scientific,
Waltham, MA, USA). Cardiac citrate synthase (CS) activity
was quantified using amethod previously described (40) with
a sample size of 10 mg of protein. The assay buffer contained
20 mM Tris, 5,59dithiobis2-nitrobenzoicacid, and 0.3 mM
acetyl CoA, pH 8.0. The reaction was initiated by the addition
of 0.5 mM oxaloacetate, and an absorbance change at 412 nm
was measured.
Activity of the b-oxidation enzyme HADHwas measured as
previously described (41) with a sample size of 20 mg of protein.
The assay buffer contained 50 mM imidazole, 0.15 mM NADH,
and 0.1% Triton X-100, pH 7.4. Recording of absorbance change
at 340 nmwas initiated 10 s after addition of 0.1 mM acetoacetyl
coenzyme A.
Hexokinaseactivitywasmeasuredwitha sample sizeof 60mg
of protein as previously described (42). The assay buffer con-
tained 20 mM imidazole, 1 mM ATP, 5 mM 7H2O.MgCl, 5 mM
DTT, 2 mM NAD+, and 3.125 U glucose-6-phosphate de-
hydrogenase, pH7.4. Recording of absorbance change at 340 nm
was initiated 10 s after addition of 5 mM glucose.
Activity of lactate dehydrogenase (LDH) was quantified es-
sentially aspreviouslydescribed (41)witha sample size of 2mgof
protein. The assay buffer contained 50 mMHEPES and 0.3 mM
NADH, pH 7.0. Recording of absorbance change at 340 nm was
initiated 10 s after addition of pyruvate.
Pyruvate dehydrogenase expression
and phosphorylation
Samples of left ventricle that had been snap frozen in liquid ni-
trogen were added to 100–150 ml of NP40 cell lysis buffer
(Thermo Fisher Scientific) containing Halt protease and phos-
phatase inhibitor cocktail (Thermo Fisher Scientific). Samples
were manually crushed then homogenized on ice using a Pellet
Pestle (MilliporeSigma, Burlington, MA, USA). Homogenates
were then snap frozen using liquid nitrogen and allowed to thaw
on ice, after which they were homogenized for a second time.
Samples underwent a further 2 freeze-thaw cycles using liquid
nitrogen, vortexing each time, before centrifugation at 16,700 g
for 10 min at 4°C. Supernatants were collected and stored at
280°C. Protein concentrationwas determined using the Bio-Rad
DC Assay (Bio-Rad). Samples were loaded into Laemmli buffer
at a concentrationof 1.5mg/mlandunderwentSDS-PAGEusing
10% acrylamide gels under reducing conditions for;1 h at 0.08
A, after which they were transferred onto PVDF membrane (GE
Healthcare, Waukesha, WI, USA) for ;1.5 h at 0.38 A. Mem-
branes were subsequently blocked for a minimum of 2 h in ei-
ther 5% (w/v) bovine serum albumin or skimmed milk in Tris-
buffered saline with Tween, as appropriate. Primary antibody
targetswere Phospho(serine 232)-PDH (1:2000; Calbiochem, San
Diego, CA, USA), Phospho(serine 293)-PDH (1:1000; Abcam,
Cambridge, MA, USA), Phospho(serine 300)-PDH (1:1000; Cal-
biochem), PDH (1:1000; Cell Signaling Technology, Danvers,
MA, USA), and b-actin (1:5000; MilliporeSigma). Secondary de-
tectionwas carriedoutusinghorseradishperoxidase–conjugated
goat anti-rabbit (1:1000; Cell Signaling Technology) or goat anti-
mouse (1:1500; Dako, Jena, Germany) antibodies. Membranes
were developed using Pierce ECL Western blotting substrate
(Thermo Fisher Scientific), and images were captured using a
ChemiDoc-It2 imager (Ultra-Violet Products, Upland, CA,USA)
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with VisionWorksLS 8.1.2. software (Ultra-Violet Products).
Images were analyzed using ImageJ (NIH) and normalized to
b-actin expression.
Statistics
In order to investigate the individual effects of hypoxic ex-
posure, dietary NO3
2, and Ppara2/2 as well as the interac-
tions between these effects, a 3-wayANOVAwas performed.
The statistical approach used has been previously described
(43). Initially, the 3-way interaction was considered for sig-
nificance. If there was a significant 3-way interaction, main
effects and 2-way interactions were disregarded, and a post
hoc Tukey’s honestly significant difference (HSD) test was
performed. Pairwise comparisons of groups between which
only one of the independent variables differed were consid-
ered, and the results were recorded. If the 3-way interaction
was not significant but $1 2-way interactions were signifi-
cant, a post hoc Tukey’s HSD test was performed to in-
vestigate each 2-way interaction. None of the main effects of
variables involved in the significant 2-way interactions were
considered, whereas the main effects of variables not in-
volved in significant interactions were. In instances where no
3- or 2-way interactions were significant, the main effects of
all 3 independent variables were considered. Main effects
combine all 4 groups in each state of 1 independent variable
and make a pairwise comparison between these combina-
tions (e.g., all 4 WT vs. all 4 Ppara2/2 groups). All analyses
were carried out using R software (The R Foundation for
Statistical Computing, Vienna, Austria), and values of P ,
0.05 were considered significant.
Graphs were generated using Prism 7 software (Graph-
Pad, La Jolla, CA, USA) and follow a color/pattern scheme
whereby white indicates normoxia (21% O2), blue indicates
hypoxia (10% O2), block color indicates chloride (Cl
2), and
striped indicates NO3
2-treated groups. In addition, the WT
groups are separated from the Ppara2/2 groups. Graphs
display results as means 6 SEM. Statistically significant dif-
ferences between groups are indicated in black (differences
between genotypes), blue (differences between normoxia
and hypoxia), and orange (interactions linked to NO3
2
treatment vs. chloride).
RESULTS
Animal data
Body mass, blood hemoglobin, and food, water, and
NO3
2 intake have been previously reported for thesemice
(35).
Briefly, food and water intake fell in hypoxic mice in
wk 2 (the first week of hypoxic exposure). Food intake
recovered in hypoxic animals over subsequent weeks,
such that itwas thesame inallgroupsat theendof thestudy.
Water intake recovered more quickly than food intake and
was the same in all groups from wk 3 onward. Inorganic
NO3
2 intake calculated from food and water intake and
over the course of the study was 153–257 mM/kg/d in
NO3
2-treated mice, compared with 18–31 mM/kg/day
in chloride-treated mice.
Body mass was the same in all WT mice at the start of
the study,butPpara2/2micewere 6%lighter thanWTs.At
the end of the study, Ppara2/2mice were 5% lighter than
WTs (P, 0.01, PPARamain effect),whereas hypoxicmice
were 4% lighter than normoxic mice (P , 0.001, hypoxia
main effect) and NO3
2-treated mice were 3% lighter than
chloride-treatedmice (P, 0.05, NO3
2main effect). [Hb]b,
whichwasmeasured at the endof the study,was higher in
hypoxic mice than normoxic mice (35).
Cardiac mitochondrial respiration
Mass-specific respiration
Assay 1 was used to measure aspects of FAO and the
control exerted by CPT1, with respiration rates initially
normalized to wet weight of tissue (Fig. 2). Mass-specific
respiration rates inPpara2/2micewere 10% (P, 0.01, Fig.
2A), 23% (P , 0.001, Fig. 2B), and 27% lower (P , 0.001,
Fig. 2C, all PPARa main effect) when limited by proton
leak (CPT1L),CPT1 flux (CPT1P), andb-oxidation (PalMP),
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Figure 2. Mitochondrial respiratory function (JO2) from assay 1 normalized to mass. A) Malate and palmitoyl CoA stimulated
LEAK respiration (CPT1L). B) CPT1-limited oxphos (CPT1P). C) Oxphos supported by the F-pathway via b-oxidation (PalMP) in
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indicate SEM. Black asterisks indicate main/PPARa effect; blue asterisks indicate hypoxia effect; n = 8–11/group. *P, 0.05, **P,
0.01, ***P , 0.001.
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respectively. Hypoxic exposure resulted in 11% lower
LEAK respiration (P , 0.01, Fig. 2A) and 13% lower
oxphos supported by b-oxidation (P, 0.05, Fig. 2C, both
hypoxia main effect). Taken together, these data con-
firm that PPARa supports FAO in the mouse heart,
whereas hypoxia suppresses themass-specific capacity for
b-oxidation.
Assay 2 was used to measure respiration supported by
FAO and substrates for the N-pathway via complex I and
the S-pathway via complex II of the ETS, with respiration
rates initiallynormalized towetweightof tissue (Fig. 3).All
respiration rates were lower in Ppara2/2 mice compared
withwild types andwere lower inhypoxicmice compared
with normoxic mice, whereas dietary NO3
2 supplemen-
tation had no effect on mass-specific respiration rates.
In Ppara2/2 mice, LEAK respiration (OctML) and
oxphos respiration (OctMP) supported by malate and
octanoyl carnitine were 21% lower (P , 0.001, Fig. 3A)
and 45% lower (P , 0.001, Fig. 3B, both PPARa main
effect) than in WTmice, underlining the role of PPARa in
regulatingcardiacFAO.Meanwhile, oxphos supportedby
pyruvate andmalate (PMP)was16% lower (P, 0.001, Fig.
3C), by glutamate andmalate (GMP) was 14% lower (P,
0.001, Fig. 3D), by glutamate, malate, and succinate
(GMSP) was 9% lower (P, 0.01, Fig. 3E), and by succinate
following the addition of rotenone (SP) was 10% lower
(P, 0.01, all PPARamain effect, Fig. 3F).
In hypoxic mice, OctML and OctMP were 16% (P ,
0.001, Fig. 3A) and 17% (P, 0.001, Fig. 3B) lower than in
normoxic mice, whereas PMP was 10% lower (P , 0.01,
Fig. 3C), GMP was 10% lower (P , 0.01, Fig. 3D), GMSP
was 10% lower (P, 0.01, Fig. 3E), and SP was 13% lower
(P, 0.01, Fig. 3F, all hypoxia main effect).
Together, these data show that both Ppara ablation and
hypoxic exposure lower oxidative capacity in the mouse
heart,with suppressionof fattyacid-supported respiration
occurring to agreater extent than respiration supportedby
other substrates. This is particularly pronounced in the
case of Ppara ablation.
CS-specific respiration
Both hypoxic exposure andPpara2/2 resulted in a general
lowering ofmass-specific respiration rates inmouse heart.
This might be attributable to a loss of cardiac mitochon-
drial content or to changes in respiration per mitochon-
drial unit, and therefore, to further probe the effects of
hypoxia,NO3
2, andPPARa onmitochondrial respiration,
we extracted the contents of the oxygraph chambers and
measured the activity of CS in chamber homogenates. CS
activity is a putativemarker ofmitochondrial content (44),
and by expressingmitochondrial respiration rates relative
to CS activity, we were able to consider respiratory ca-
pacities per mitochondrial unit.
In assay 1, hypoxia had no effect on anyCS-corrected
respiration rate (Fig. 4). DietaryNO3
2 supplementation
increased CPT1L by 38% (P , 0.01, Fig. 4A), CPT1P by
33% (P, 0.05, Fig. 4B), and PalMP by 36% (P, 0.01, Fig.
4C, all Tukey’s test of NO3
2/PPARa interaction) inWT
but not Ppara2/2mice. Ppara knockout lowered all CS-
corrected respiration rates. In normoxic mice, Ppara
knockout lowered CPT1L by 25% (P , 0.05, Fig. 4A),
CPT1P by 38% (P , 0.001, Fig. 4B), and PalMP by 38%
(P , 0.001, Fig. 4C, all Tukey’s test of hypoxia/PPARa
interaction). In NO3
2-supplementedmice, Ppara knockout
loweredCPT1L by 23% (P, 0.05, Fig. 4A), CPT1P by 34%
(P, 0.001, Fig. 4B), andPalMPby 35% (P, 0.001, Fig. 4C,
all Tukey’s test of NO3
2/PPARa interaction). Taken
together, these data suggest that Ppara ablation at-
tenuates FAO capacity per mitochondrial unit and that
NO3
2 increases FAOpermitochondrial unit in aPPARa-
dependent manner.
InAssay 2, neitherNO3
2 supplementation nor hypoxic
treatment affected CS-corrected respiration rates (Fig. 5).
Ppara ablation, however, lowered CS-corrected OctML by
25% (P, 0.01, Fig. 5A), OctMP by 27% (P, 0.001, Fig. 5B),
PMPby19%(P, 0.05, Fig. 5C), andGMPby17% (P, 0.05,
Fig. 5D, all PPARa main effect). GMSP and SP were un-
affected byNO3
2, hypoxia, or genotype (Fig. 5E, F). These
data further support the notion that Ppara ablation atten-
uates cardiac mitochondrial FAO capacity, in addition to
any effect on mitochondrial content.
Oxphos coupling efficiency
Oxphos coupling efficiency, indicating the increase in
respiration following addition of ADP relative to the
resulting respiration rate, was calculated for both assays
(Supplemental Fig. S1). In assays 1 and 2, oxphos coupling
efficiencywas 19 and 29% lower, respectively, inPpara2/2
mice compared with WT mice (P , 0.001, PPARa main
effect). Neither NO3
2 supplementation nor hypoxic ex-
posure affected oxphos coupling efficiency. These data
suggest that although PPARa enhanced fatty acid-
supported respiration in both LEAK and oxphos states,
the effect on the oxphos state was proportionally greater.
Substrate control ratios
To further investigate the effects of NO3
2 supplementa-
tion, hypoxic exposure, and PPARa on cardiac mito-
chondrial respiration and the interactions between these 3
factors, we used substrate control ratios to interrogate
control points and substrate-led pathways (Fig. 6).
Firstly, to understand the effect of these factors on the
activity of CPT1 (an enzyme responsible for the entry of
long chain fatty acid substrates into mitochondria via
the addition of carnitine), we expressed CPT1P relative
to PalMP (FCRCPT1, Fig. 6A). Here, we found that the
substrate control ratio was unaffected by any factor. This
indicates that although oxphos supported by CPT1 sub-
strates and oxphos supported by b-oxidation are sup-
pressed in Ppara2/2mice and hypoxic mice, the effects on
these 2 respiration rates are proportionally similar.
Next, we sought to understand the contribution of 3
substrate-led pathways to total oxphos capacity, express-
ingoxphos supportedby:1) theF-pathwayviab-oxidation
(OctMP), 2) theN-pathway via complex I (GMP), and 3) the
S-pathway via complex II (SP), relative tomaximal oxphos
(GMSP).
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Figure 3. Mitochondrial respiratory function (JO2) from assay 2 normalized to mass. A) Malate and octanoyl carnitine stimulated
LEAK respiration (OctML). B) Oxphos supported by the F-pathway via b-oxidation (OctMP). C) Oxphos supported by pyruvate
and malate through the N-pathway via complex I (PMP). D) Oxphos supported by glutamate and malate through the N-pathway
via complex I (GMP). E) Oxphos supported by glutamate, malate, and succinate through the NS-pathway via complexes I and II
(GMSP). F) Oxphos supported by succinate following the addition of rotenone (SP) in permeabilized cardiac muscle ﬁbers from
Ppara+/+ and Ppara2/2 mice following normoxia (white bars, 21% O2) or hypoxia (blue bars, 10% O2) and chloride (open bars,
0.7 mM NaCl) or NO3
2 (striped bars, 0.7 mM NaNO3) supplementation. Error bars indicate SEM. Black asterisks indicate main/
PPARa effect; blue asterisks indicate hypoxia effect; n = 8–11/group. *P , 0.05, **P , 0.01, ***P , 0.001.
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In WT, but not Ppara2/2 mice, exposure to hypoxia
lowered oxphos respiration through the F-pathway rela-
tive tomaximal oxphos (FCRF) by 32% (P, 0.001, Tukey’s
test of hypoxia/PPARa interaction, Fig. 6B). Similarly, this
was41% lower innormoxicPpara2/2mice comparedwith
WT mice. This suggests that hypoxic exposure lowers
FAO relative to maximal oxphos in a PPARa-dependent
manner.
Oxphos supported by the N-pathway via complex I,
relative to maximal oxphos (FCRN), was 7% lower in
Ppara2/2 mice compared with WT mice (P , 0.001,
PPARa main effect, Supplemental Fig. S2A) but was
unaffected by hypoxic exposure or NO3
2 supplemen-
tation.Meanwhile, oxphos supported by the S-pathway
via complex II (FCRS) was unaffected by Ppara ablation
or hypoxia but was 2% higher in NO3
2-supplemented
mice (P , 0.05, NO3
2 main effect, Supplemental
Fig. S2B).
Finally, we expressed octanoyl carnitine-supported
oxphos (OctMP) relative to pyruvate-supported oxphos
(PMP) in order to indicate the relative capacity for FAO
compared with pyruvate-linked respiration through the
N-pathway (FCROct/P, Fig. 6C). The relative capacity for
FAOwasdecreased byhypoxia in chloride-supplemented
WT mice by 18% (P , 0.001, Tukey’s test of NO3
2/
hypoxic/PPARa interaction) but not in NO3
2-supple-
mentedWTmice nor in either group of hypoxic Ppara2/2
mice. Dietary NO3
2 reversed this effect in hypoxic WT
mice, increasing the relative capacity for FAO by 17%
(P, 0.05, Tukey’s test ofNO3
2/hypoxia/PPARa).Again,
no effect was seen in Ppara2/2mice. The relative capacity
for FAOwas, however, lower inPpara2/2mice (P, 0.001,
Tukey’s test of NO3
2/hypoxia/PPARa interaction).
These data therefore demonstrate that in mouse heart: 1)
Ppara ablation induces a substrate switch away from fatty
acids, 2) exposure to hypoxia induces a substrate switch
away fromfattyacidsactingviadecreasedPPARa activity,
and 3) dietary NO3
2 prevents the hypoxia-induced sub-
strate switch in a PPARa-dependent manner.
Enzyme activities
Hypoxic exposure resulted in 32% lower CS activities in
WTmouse hearts compared with those of their normoxic
counterparts (P , 0.05, Tukey’s test of hypoxia/PPARa
interaction), but it did not affect CS activity in Ppara2/2
mice (Fig. 7A).
NO3
2-supplemented WT mice had 33% higher activi-
ties of the b-oxidation enzymeHADH in heart (P, 0.01),
whereas no effect was seen in Ppara2/2 mice (Fig. 7B).
Moreover, in Ppara2/2 mice supplemented with NO3
2,
but not by chloride,HADHactivitywas35% lower than in
WT counterparts (P, 0.01, Tukey’s test of NO3
2/PPARa
interaction). This suggests that dietary NO3
2 increases
HADH activity in cardiac tissue via a PPARa-dependent
mechanism.
Hexokinase activity was 33% higher in hypoxic
groups relative to normoxic counterparts (P , 0.001,
hypoxia main effect), with no significant effect on
hexokinase activity resulting from NO3
2 supplemen-
tation or genotype (Fig. 7C). Hypoxia also increased
LDH activity by 71% inWT but not Ppara2/2mice (P,
0.001, Tukey’s test of hypoxia/PPARa interaction, Fig.
7D). Hypoxia was also permissive of a PPARa effect
because, under hypoxic but not normoxic conditions,
Ppara ablation resulted in 50% lower LDH activities
(P , 0.001, Tukey’s test of hypoxia/PPARa inter-
action). Dietary NO3
2 did not affect the activity of
either hexokinase or LDH. Thus, hypoxia increased
hexokinase activity in a manner that was independent
of dietary NO3
2 and PPARa but increased LDH in a
manner that was dependent upon PPARa.
Pyruvate dehydrogenase levels
and phosphorylation
To examine the regulation of pyruvate oxidation, total and
phosphorylated PDH levels were measured in cardiac
homogenates by immunoblotting. There was no specific
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effect of hypoxia on total PDH levels (Fig. 8A), although
total levels were higher in hypoxic NO3
2-supplemented
WTmice comparedwith their normoxic counterparts (P,
0.05, Tukey’s test of hypoxia/NO3
2/PPARa interaction).
Hypoxia increased phosphorylation of PDH at serine
residues 232, 293, and 300 in WT mice, and this was pre-
vented by NO3
2 supplementation (P, 0.01, Tukey’s test
of hypoxia/ NO3
2/PPARa interaction, Fig. 8B–D). There
was no clear effect of hypoxia on phosphorylation of any
serine residue in Ppara2/2 mice. At serine 232, NO3
2
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2 (striped bars, 0.7 mM NaNO3) supplementation. Error bars indicate SEM. Black
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supplementation appeared to enhance phosphorylation in
hypoxicPpara2/2mice (P, 0.05, Tukey’s test of hypoxia/
NO3
2/PPARa interaction, Fig. 8B). Overall, these data
suggest hypoxia increases PDH inhibition by phosphory-
lation in a PPARa-dependent manner, whereas NO3
2
prevents this.
DISCUSSION
We have previously demonstrated that a moderate dose
of dietary NO3
2 protects mitochondrial respiratory func-
tion, FAO, and energetics in the hypoxic rat heart (33) and
enhances skeletal muscle FAO capacity through a mech-
anism dependent upon activation of PPARa (34). De-
creasedPPARa transcriptional activity appears to be a key
aspect of the cardiac metabolic response to hypoxia (8, 9),
so here we sought to understand whether PPARa plays
a role in mediating the protective effect of NO3
2 in the
hypoxic heart.
We found that hypoxic exposure was associated with
the suppression of mass-specific respiratory capacity and
CS activity in mouse heart, with no protective effect
of NO3
2. Mass-specific respiration was also lower in
Ppara2/2 mice compared with WT mice. Hypoxia in-
creased phosphorylation of PDH in WT mice and also
increased the capacity for glycolysis with increased
hexokinase activity in allmice and increasedLDHactivity
in WT mice. In addition to the general suppression of
oxidative capacity, hypoxia resulted in aparticulardown-
regulationof FAOcapacity inWTmice. Thiswas reversed
by NO3
2 treatment, an effect not apparent in Ppara2/2
mice. Similarly, NO3
2 increased activity of HADH inWT
mice but not Ppara2/2mice.
Strengths of this study include the use of high-
resolution measurements of oxygen flux to consider
multiple aspects of FAO capacity with both CPT1-
dependent and independent substrates. Our inclusion
of both mass-specific and mitochondrial-specific FAO
capacity measurements as well as FAO in proportion to
maximal oxphos capacity is also a strength. It should be
noted, however, that allmeasurementswere carried out
under conditions in which oxygen and substrates were
saturating, and although our data indicate alterations
in respiratory capacity, there may be further, subtle
differences in mitochondrial respiration in vivo at
physiologic oxygen and substrate concentrations that
we have not measured here. The use of permeabilized
fibers, rather than isolated mitochondria, allowed us
to measure respiration in the entire population of
cardiac mitochondria, albeit without allowing us to
distinguish between effects on the interfibrillar and
subsarcolemmal populations of mitochondria (45). A
further strength of this study was the statistical ap-
proach, which, although complex, allowed us to di-
rectly address the key hypothesis that NO3
2 exerts
effects in hypoxia acting through PPARa. The 3-way
ANOVA approach allowed us to test the interaction
between these 3 factors and represented a conservative
approach, eliminating the need for multiple compari-
sons and strengthening the conclusions of this study.
This approach, however, does increase the chance
of type 2 errors and is not suitable for testing differ-
ences between just 2 of the groups [e.g., the effect of
hypoxia on WT (non-NO3
2-supplemented) mice], for
which a more targeted study design would be more
appropriate.
Theuse ofmice, rather than rats, is both a strength anda
weakness of this study. The Ppara2/2 mouse has been
studied extensively, particularly in relation to the role of
PPARa in regulating FAO in various tissues, and was a
valuable component of this study. Mice, however, differ
from rats and humans in their NO production rates (46)
and concentrations of circulatingNO3
2/NO2
2 levels (47).
Moreover, we only used male mice in this study, which
may be a limitation because, for example, gender di-
morphic differences in the antiplatelet response to NO3
2
supplementation have been observed in humans (48). As
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with our previous studies, we were able to precisely con-
trol NO3
2 intake using a standardized quality-controlled
diet and deionized water (23, 33–35, 49, 50). Although the
anorexic effects in the early stages of hypoxic exposure
may have confounded our findings, the long duration of
the hypoxic exposure proved to be a strength because
water intake and therefore NO3
2 intake stabilized in
hypoxic mice by wk 2, matching that of their normoxic
counterparts for the remainder of the study.
Unlike our previous findings in rat heart (33), however,
we saw no protective effect of NO3
2 supplementation on
mass-specific oxphos. This could be due to species differ-
ences, indeed 17 mo of NaNO3 supplementation at 1 mM
did not alter plasma NO3
2 concentration in mice (51),
whereas 0.7 mM NaNO3 increased circulating NO3
2 in
rats (33). It should be noted, however, that both the du-
ration (4 wk) and degree of hypoxia (10% O2) were more
severe in this study than inourpreviouswork (2wkat 13%
O2), and this may have limited the effectiveness of NO3
2
supplementation. Of note, the increased activity of LDH is
an established hypoxia response in the heart (52), and this
was seen in both chloride-supplemented and NO3
2-sup-
plemented mice, perhaps suggesting that NO3
2 supple-
mentation did not fully restore O2 delivery to these hearts.
The general suppression of mass-specific respiratory
capacity, particularly in the context ofmoreprolongedand
severe hypoxia, might be explained by a loss of mito-
chondrial content in these hearts. Indeed, we saw that
hypoxia lowered CS activity in the hearts of WT mice in
this study, whereas therewas no such change in CS in our
previous study that employed a milder hypoxia protocol
(33). In skeletalmuscle, the suppressionofCS isdependent
on both duration anddegree of hypoxia (53). CS activity is
a putative marker of mitochondrial density, correlating
with mitochondrial volume in the skeletal muscle of
healthy, young adult humans (44), although whether this
correlation holds in the mouse heart under all conditions
described here is unknown.
In addition to the general effect of hypoxia on mass-
specific respiration, a particular suppression of FAO was
seen. This was indicated by a fall in CS-corrected respira-
tion rates for fatty acid substrates and also by substrate
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Figure 7. Enzyme activities in mouse heart tissue homogenates. Maximal activity of CS (A), HADH (B), hexokinase (C), and LDH
(D) from Ppara+/+ and Ppara2/2 mice, following normoxia (white bars, 21% O2) or hypoxia (blue bars, 10% O2) and chloride
(open bars, 0.7 mM NaCl) or NO3
2 (striped bars, 0.7 mM NaNO3) supplementation. Error bars indicate SEM. Symbols in brackets
denote signiﬁcance of a test of a combination of groups (i.e., main effects or 2-way interactions); n = 4–5/group. ***P , 0.001
(hypoxia main effect), DDP , 0.01 (NO3
2 effect following NO3
2/PPARa interaction), DDDP , 0.001 (hypoxia effect following
hypoxia/PPARa interaction), DDP , 0.01 (PPARa effect following NO3
2/PPARa interaction), DDDP , 0.01, (PPARa effect
following hypoxia/PPARa interaction).
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control ratios expressing FAO as a proportion of maximal
oxphos or in relation to pyruvate-supported oxphos. This
effect of hypoxia was seen in the hearts of WT but not
Ppara2/2mice, indicating that the hypoxic suppression of
FAO is primarily driven by decreased PPARa activity, as
suggested previously (8). There was no specific effect on
CPT1-supported FAO (with palmitoyl CoA plus malate)
compared with CPT1-independent respiration (with pal-
mitoyl carnitine plus malate), indicating that although
CPT1 activity may be down-regulated, there are also ef-
fects of a similar magnitude downstream, probably on
b-oxidation capacity, although in agreement with our
previous work (9) HADH activity was unaltered by
hypoxia. Although the severity of the hypoxic stimulus
used here may have prevented any restorative effect of
NO3
2 onmass-specific respiration, NO3
2 did prevent the
particular suppression of FAO, but only in WT mice,
suggesting that PPARa is necessary for these NO3
2-
mediated effects to occur. Moreover, NO3
2 supplemen-
tation increased HADH activity in the hearts of WTmice
but not Ppara2/2mice.
In addition to the effect of hypoxia, mass-specific re-
spiratory capacity was lower in the hearts of Ppara2/2
mice than those ofWTmice, and asmight be expected, this
was most pronounced for respiration rates supported by
fatty acid substrates, althougha suppressionof respiration
supported by substrates for the N-pathway via complex I
(pyruvate, glutamate, and malate) and the S-pathway via
complex II (succinate) was also seen. When corrected for
CS activity, respiration supported by fatty acid substrates
remained lower in Ppara2/2 mice compared with WT
mice, underlining its importance in regulating cardiac
FAO, but of note, respiration supported by N-pathway
substrates was also lower in Ppara2/2mice. Unlike inWT
mice, there was no effect of NO3
2 supplementation on
FAO capacity or HADH activity in Ppara2/2 mice, dem-
onstrating that PPARa is an essential mediator of the ef-
fects of NO3
2 on cardiac metabolism in hypoxia, which is
in line with our initial hypothesis.
Activities of hexokinase and LDH were increased fol-
lowing hypoxia as did PDH phosphorylation, all sug-
gesting an up-regulation of glycolytic capacity. Although
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Figure 8. Total PDH levels and phosphorylation. A) Protein levels of total PDH. B–D) Phosphorylation of PDH at E1a site serine
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0.7 mM NaNO3) supplementation. Error bars indicate SEM. Two-way interaction (D); 3-way interaction (†); hypoxia effect (blue D,
†); PPARa effect (black D, †); n = 8–10/group. †P , 0.05, DDP , 0.01; ††P , 0.01, †††P , 0.001.
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the increase in hexokinase activity was not dependent on
PPARa, occurring in mice of both genotypes, the increase
inLDHdehydrogenase activity only occurred inWTmice,
suggesting an unexpected influence of PPARa on Ldh ex-
pression. PPARb/d has been shown to decrease the ex-
pression ratio of Ldha/Ldhb in skeletal muscle (54), but we
arenot awareof anypreviously reportedeffects ofPPARa.
Whereas Ldhb encodes an LDH isoform that encourages
the conversion of lactate to pyruvate, the protein product
of Ldha favors the conversion of pyruvate to lactate. It is
plausible, therefore, that PPARa ablation is compensated
by an increase in PPARb/d, which prevents a hypoxia-
induced increase in Ldha/Ldhb, though thiswould have to
be confirmed with gene expression studies. Alternatively,
PPARa is known to increase PDK4 activity, leading to an
attenuation of PDH activity. This could increase pyruvate
concentration, which may feed forward to increase LDH
activity. Indeed, whereas hypoxia increased PDH phos-
phorylation in WT mice, potentially via HIF-dependent
up-regulation of PDK1 (6, 7), this effect was blunted in
Ppara2/2 mice. Taken together, these data implicate a
switchaway fromoxidativemetabolismtowardglycolysis
in the hypoxic mouse heart.
Our data therefore suggest that PPARa plays a key role
in regulating the process of metabolic remodeling that
occurs in the hypoxic heart and that PPARa is essential for
the effects of dietary NO3
2 in preserving oxidative me-
tabolism. This is in contrast to our previous findings in
skeletal muscle in which the metabolic response to hyp-
oxia +/2NO3
2was found to be the same inWTmice and
Ppara2/2 mice (35). The difference between the 2 tissues,
and the greater dependence on PPARa in the heart, might
be explained by the higher expression of PPARa in cardiac
muscle compared with skeletal muscle (3). NO3
2 supple-
mentation did exert effects in hypoxic skeletal muscle, but
this may have been due to effects via PPARb/d (36) or
through hemodynamic changes that alter blood flow and
O2 delivery (20). Our data do not definitively address
whetherNO3
2 exerts its effects by altering blood flow and
therefore O2 delivery or through direct effects on tissue
metabolism. Although PPARa is an essential effector in
this response, its transcriptional activity may simply be
modified byHIF signaling in response to changes in tissue
oxygenation in order to ensure that oxidative metabolism
is supported only when sufficient oxygen is available.
Arguing against this is our finding here that hexokinase
and LDH activity were increased by hypoxia in both
chloride-supplemented and NO3
2-supplemented hearts,
indicating that although the dose of NO3
2 employed here
did modulate FAO, it was not sufficient to ameliorate the
fall in oxygenation through improved blood flow. More-
over, our previous work in cultured myotubes indicated
that NO3
2 enhanced PPARa activity without changes in
oxygenation (34), and it would be interesting to replicate
this in cardiomyocytes. It seems likely that NO3
2 exerts
complementary but separate effects on blood flow and
metabolism, ensuring that tissue O2 supply and demand
are matched.
Our work has implications for a number of conditions
in which cardiac and skeletal muscle metabolism is path-
ologically altered,particularlywherederangements inNO
production or availability have been implicated. For
instance, eNOS knockout mice develop a metabolic
syndrome-like phenotype, including obesity and insulin
resistance, yet features of the pathology were reversed
following NO3
2 supplementation (55). It has been sug-
gested that NO3
2 supplementation may be of benefit to
patients with heart failure with reduced ejection fraction
in whom eNOS activity is impaired (56). A recent study
demonstrated improvements in NO bioavailability and
muscle power following NO3
2 supplementation in 9 pa-
tientswith heart failurewith reduced ejection fraction (56),
and it would be interesting to see if this was associated
with changes in tissue metabolism in addition to im-
provements inblood flow.The failingheart itself is energy-
starved (57) and characterized by a down-regulation of
FAO (1, 57), which may improve the efficiency of O2 uti-
lization. Itwas shown, however, that oxygenationwas not
impaired in the nonischemic failingmyocardium (58), and
thus therapeutic strategies that enhance oxidative metab-
olism, including perhaps NO3
2 supplementation, may be
of benefit to these patients.
In summary, hypoxia suppresses oxidative metabolism
in the heart and enhances glycolytic capacity. In addition,
there is aparticular suppressionof FAO in thehypoxic heart
that is mediated through decreased PPARa transcriptional
activity and that can be reversed by supplementation with
dietary NO3
2 in a PPARa-dependent manner.
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